Ira Jay Goldberg MD

Diabetes, Lipid Metabolism

Director, Division of Endocrinology, Diabetes, and Metabolism

530 1st AvenueSuite 5ENew York, NY 10016
Phone+1 212-481-1350

Dr. Goldberg is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Goldberg's full profile Already have an account?

Education & Training

Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalFellowship, Endocrinology, Diabetes, and Metabolism, 1978 - 1979
Harvard Medical SchoolClass of 1975
Massachusetts Institute of TechnologyB.S., 1971

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

NY State Medical License 1976 - 2027
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Awards, Honors, & Recognition

CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017
CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2014, 2016-2017
Member Association of American Physicians, 1999

Publications & Presentations

PubMed

Validation of Brachial Vein Endothelial Transcriptomics to Assess the Coronary Vasculature.
Michael S Garshick, Florencia Schlamp, Isabelle Boothman, Tessa J Barrett, Filipp Kazatsker
Circulation Research. 2026-07-06
The N-terminus of apolipoprotein B mediates the interaction of atherogenic lipoproteins with endothelial cells.
Ainara G Cabodevilla, Camila Calistru, Waqas Younis, Dimitris Nasias, Tse Ww Ho
The Journal of Clinical Investigation. 2026-06-15
Cardiac Lipid Metabolism: Cells, Metabolites, and Rhythms.
Ira J Goldberg, Martin E Young, P Christian Schulze, Konstantinos Drosatos
Circulation Research. 2026-06-05

Journal Articles

Myeloperoxidase: A Therapeutic Target for Preventing Insulin Resistance and the Metabolic Sequelae of Obesity?
Heinecke JW, Goldberg IJ, Diabetes, 1/1/2014
Cardiac Metabolic Compensation to Hypertension Requires Lipoprotein Lipase
Yamashita H, KG. Bharadwaj, S Ikeda, T-S Park, IJ Goldberg, A J Physio, Endo/Metab, 1/1/2008
In vivo arterial lipoprotein lipase expression augments inflammatory responses and impairs vascular dilatation
Takahashi M, M Yokoyama, Y Hiyama, Y Hu, K Melford, A Bensadoun, IJ Goldberg, ATVB, 1/1/2008

Books/Book Chapters

Cardiac Energy Metabolism in Health and Disease.
Chapter: Lipoproteins: A Source of Cardiac Lipids.
Page 15 - 33K Drosatos, IJ GoldbergEditors: Gary D. Lopaschuk, Naranjan S.Dhalla.Springer2014
Williams Endocrinology
Chapter: Chapter 37: Lipid and lipoprotein disorders.
Page 1633 - 1674Semenkovich C, A Goldberg, IJ Goldberg2011
Therapeutic Lipidology
Chapter: Management of Hypertriglyceridemia.
Page 201 - 220Labossiere R and IJ GoldbergEditors: MH Davidson, PP Toth, KC Maki.Humana Press2007

Lectures

Diabetes and Hypertriglyceridemia: Cardiovascular Risk, Mechanisms, and Indications for Treatment
ENDO 2019 - New Orleans, LA - 3/26/2019
Hepatic Substrate Metabolism and Cardiometabolic Disease
ENDO 2018: 100th Endocrine Society Annual Meeting - Chicago, Illinios - 03/18/2018
Endocrinology Board Review, Endocrinology Society
San Francisco - 9/2/2014

Press Mentions

Newfound Mechanism May Explain Why Some Cancer Treatments Boost Risk of Heart DiseaseDecember 3rd, 2024
Newfound Mechanism May Explain Why Some Cancer Treatments Boost Risk of Heart DiseaseDecember 2nd, 2024
Arrowhead Pharmaceuticals to Host Key Opinion Leader Webinars on Cardiometabolic Candidates ARO-APOC3 and ARO-ANG3November 4th, 2020

Grant Support

Training Program in Cardiometabolic DiseasesNEW YORK UNIVERSITY SCHOOL OF MEDICINE2009–2030
Cholesterol reduction and cardiovascular risk in Type 1 diabetesNEW YORK UNIVERSITY SCHOOL OF MEDICINE2022–2027
Chylomicrons and endothelial biologyNEW YORK UNIVERSITY SCHOOL OF MEDICINE2023–2026
Chylomicrons and endothelial biologyNEW YORK UNIVERSITY SCHOOL OF MEDICINE2023–2026
Pathways of Tissue Lipid UptakeNEW YORK UNIVERSITY SCHOOL OF MEDICINE1991–2025